2021 annual financial data
Atrium Therapeutics 2021 Operating margin
Direct answer
Operating margin was -1,265.83%.
Operating income was -118.05M USD and net income was -117.37M USD.
Operating cash flow was -94.81M USD.
Get free Atrium Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 9.33M USD
- Operating income
- -118.05M USD
- Net income
- -117.37M USD
- Operating cash flow
- -94.81M USD